Micro-elimination of HCV as a possible therapeutic strategy: our experience and a review of literature | Zendy

Ksenija Bojović | Zendy; Jasmina Simonovic-Babic | Zendy; Željko Mijailović | Zendy; Ivana Milošević | Zendy; Maja Jovanović | Zendy; Maja Ružić | Zendy; Tatjana Cvejic Pasic | Zendy; Petar Svorcan | Zendy; Milena Petrovic | Zendy; Jelena Jordović | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Micro-elimination of HCV as a possible therapeutic strategy: our experience and a review of literature

Author(s) -

Ksenija Bojović,

Jasmina Simonovic-Babic,

Željko Mijailović,

Ivana Milošević,

Maja Jovanović,

Maja Ružić,

Tatjana Cvejic Pasic,

Petar Svorcan,

Milena Petrovic,

Jelena Jordović

Publication year - 2020

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.11785

Subject(s) - medicine , haemophilia , hepatitis c , epidemiology , chronic hepatitis , intensive care medicine , pediatrics , immunology , virus

Serbia has an intermediate estimated prevalence of chronic hepatitis C (CHC) infection, approximately 1.13%, with hepatitis C remaining one of the leading causes of liver-related morbidity and mortality in Serbia with impaired quality of life and overwhelming cost of treating its complications As the availability of new treatment options and resources for screening remains limited, micro-elimination of CHC becomes a top priority.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research